The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapies
Under a Creative Commons license
open access
Keywords
Relapsed/refractory multiple myeloma
Age
Elderly
Comorbidities
Retrospective analysis
Renal insufficiency
Cardiovascular disease
Treatment
Cited by (0)
- 1
A wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
© 2017 The Author(s). Published by Elsevier Ltd.